Pinnacle Wealth Planning Services
ALNY icon

Pinnacle Wealth Planning Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$110K Buy
446
+168
+60% +$42.8K 0.01% 811
2026
Q2 		$83.5K Sell
278
-228
-45% -$68.8K 0.01% 965
2026
Q1 		$167K Buy
506
+457
+933% +$156K 0.02% 544
2025
Q4 		$19.3K Buy
+49
New +$21.7K ﹤0.01% 1735
2021
Q1 		– Sell
-34
Closed -$4K – 404
2020
Q4 		$4K Buy
+34
New +$4.54K ﹤0.01% 1706

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Pinnacle Wealth Planning Services's ALNY Position: Q3 2026 in Review

Pinnacle Wealth Planning Services increased its Alnylam Pharmaceuticals (ALNY) stake by 60% in Q3 2026, buying an estimated $42.8K and bringing the position to 446 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #811.

Pinnacle Wealth Planning Services first reported a position in ALNY in Q4 2020 and has held it in 5 quarters since. The position peaked at $167K in Q1 2026. 591 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • Pinnacle Wealth Planning Services held 446 shares of Alnylam Pharmaceuticals worth $110K as of Q3 2026.
  • Pinnacle Wealth Planning Services bought 168 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $42.8K.
  • Alnylam Pharmaceuticals made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #811 holding.
  • Pinnacle Wealth Planning Services first reported a position in Alnylam Pharmaceuticals in Q4 2020 and has held it in 5 quarters since.
  • Pinnacle Wealth Planning Services's Alnylam Pharmaceuticals position peaked at $167K in Q1 2026.
  • 591 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.